Welcome to our dedicated page for Harte Hanks SEC filings (Ticker: HHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the numbers behind Harte Hanks’ data-driven marketing engine? Investors typically open the company’s filings to see how cyclical client budgets affect revenue, whether Customer Care margins are expanding, and how logistics costs move the bottom line. Yet a single Harte Hanks annual report 10-K can exceed 250 pages—hardly light reading.
Stock Titan distills every Harte Hanks SEC filing into plain language. Our AI-powered summaries flag segment performance in the 10-K, spotlight cash-flow shifts in the Harte Hanks quarterly earnings report 10-Q filing, and translate 8-K material events explained in minutes. Need to monitor Harte Hanks insider trading Form 4 transactions? Receive real-time alerts the moment a director buys or sells. Curious about the proxy statement executive compensation tables? We highlight pay structures and incentive metrics without the jargon.
Use cases go further: track Harte Hanks executive stock transactions Form 4 to gauge management sentiment; compare marketing-services growth quarter over quarter with our earnings report filing analysis; or get notified when a new contract announcement hits EDGAR so you can act before the market does. Whether you’re understanding Harte Hanks SEC documents with AI or simply want Harte Hanks SEC filings explained simply, Stock Titan delivers every document—10-K, 10-Q, 8-K, Form 4—complete with expert context and historical trends, all updated in real time.
Harte Hanks reported lower revenue and a small net loss for the quarter ended June 30, 2025.
Revenue fell to $38.6 million for the quarter (down 14.2% year-over-year) and $80.2 million for the six months (down 11.4%). The company recorded a net loss of $0.3 million for the quarter and $0.7 million for six months, equal to basic and diluted losses per share of $0.05 and $0.10, respectively. Cash and cash equivalents declined to $4.8 million at June 30, 2025. Operating expenses declined year-over-year (11.6% for the quarter; 9.6% for six months) as the company reduced labor and other costs and continued its transformation program, Project Elevate, which targets $16.0 million of cumulative savings. The company extended its asset-based revolving Credit Facility to June 30, 2028 and had $24.0 million of borrowing availability after letters of credit.
FAQ
What is the current stock price of Harte Hanks (HHS)?
What is the market cap of Harte Hanks (HHS)?
